Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1



Status:Completed
Conditions:Psychiatric, Psychiatric, Gastrointestinal
Therapuetic Areas:Gastroenterology, Psychiatry / Psychology
Healthy:No
Age Range:18 - 59
Updated:1/13/2017
Start Date:April 1996
End Date:June 1997

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

CS1008 A&B Eff/Safety Trial of BUP/NX for the Treatment of Opiate Dependence

The purpose of this study is the use of buprenorphine/naloxone in treatment of opioid
dependence.

The objective of this study is to determine the safety and efficacy of a
buprenorphine/naloxone combination tablet for opiate dependence treatment.

Inclusion Criteria:

DSM-IV diagnosis of current opiate dependence males and non-pregnant, non-nursing female
18-59 yrs of age

Exclusion Criteria:

Any significant medical condition AST or ALT levels greater than 3x's the upper limit of
normal level Current Axis I diagnosis other than opiate, caffeine or nicotine dependence
We found this trial at
1
site
New York MDRU
New York, New York 10010
?
mi
from
New York, NY
Click here to add this to my saved trials